Kirsten Ward-Hartstonge
Kirsten Ward-Hartstonge is a postdoctoral fellow from the University of Otago, New Zealand. Kirsten’s research interests involve using high-dimensional flow cytometry to understand human diseases and to monitor outcomes in clinical trials.
Kirsten completed her PhD in 2018 which involved the investigation of T cell subsets associated with patient outcomes in colorectal cancer. She then moved to Canada in 2019 for a postdoctoral fellowship position at the University of British Columbia. Here, Kirsten worked on multiple clinical trials where she used flow cytometry to monitor the immune responses of patients to determine if there were immune biomarkers that were associated with a response to the trial interventions. In 2021, Kirsten moved back to New Zealand where she is currently working on the development of a platform to enable clinical researchers to access high-dimensional flow cytometry to monitor immune responses in cancer clinical trials in New Zealand.
Abstracts this author is presenting:
